IRIS
DE VITO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.478
AS - Asia 3.361
SA - Sud America 1.882
EU - Europa 1.821
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 140
OC - Oceania 6
AN - Antartide 1
Totale 19.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.204
BR - Brasile 1.669
SG - Singapore 1.473
IT - Italia 750
CN - Cina 570
HK - Hong Kong 431
VN - Vietnam 345
DE - Germania 275
FR - Francia 151
FI - Finlandia 140
GB - Regno Unito 125
CA - Canada 115
AR - Argentina 79
IN - India 78
BD - Bangladesh 68
MX - Messico 63
TR - Turchia 52
UA - Ucraina 52
RU - Federazione Russa 49
NL - Olanda 43
EC - Ecuador 37
IQ - Iraq 37
ZA - Sudafrica 36
PK - Pakistan 34
ES - Italia 32
JP - Giappone 30
VE - Venezuela 30
CO - Colombia 28
PL - Polonia 28
ID - Indonesia 25
CZ - Repubblica Ceca 24
MA - Marocco 24
UZ - Uzbekistan 23
SE - Svezia 22
AE - Emirati Arabi Uniti 21
AT - Austria 21
JM - Giamaica 20
KR - Corea 20
IL - Israele 19
LT - Lituania 17
NP - Nepal 15
BE - Belgio 13
CR - Costa Rica 12
KE - Kenya 12
KG - Kirghizistan 12
SA - Arabia Saudita 12
TN - Tunisia 12
AZ - Azerbaigian 11
PS - Palestinian Territory 11
UY - Uruguay 11
IE - Irlanda 10
JO - Giordania 10
MY - Malesia 10
RS - Serbia 10
CL - Cile 9
DO - Repubblica Dominicana 9
NI - Nicaragua 9
RO - Romania 9
UG - Uganda 9
HN - Honduras 8
LB - Libano 8
PE - Perù 8
PH - Filippine 8
BG - Bulgaria 7
PY - Paraguay 7
SN - Senegal 7
AU - Australia 6
CW - ???statistics.table.value.countryCode.CW??? 6
DZ - Algeria 6
EG - Egitto 6
GT - Guatemala 6
AL - Albania 5
GE - Georgia 5
GP - Guadalupe 5
HU - Ungheria 5
KZ - Kazakistan 5
OM - Oman 5
PR - Porto Rico 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AM - Armenia 4
CI - Costa d'Avorio 4
DK - Danimarca 4
EE - Estonia 4
MK - Macedonia 4
PA - Panama 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
GR - Grecia 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BW - Botswana 2
BZ - Belize 2
CH - Svizzera 2
ET - Etiopia 2
Totale 19.656
Salva come PNG Salva come JPEG
Città #
Dallas 7.706
Singapore 780
San Jose 666
Ashburn 535
Hong Kong 427
Chandler 345
Council Bluffs 314
Santa Clara 243
New York 239
Beijing 217
Columbus 166
Munich 165
São Paulo 132
Los Angeles 117
Lauterbourg 110
Ho Chi Minh City 105
Helsinki 101
Milan 97
Hanoi 79
Princeton 68
Sassari 63
Rio de Janeiro 60
Shanghai 57
Rome 53
Belo Horizonte 51
Phoenix 43
Montreal 40
The Villages 40
Atlanta 39
Brasília 39
Cagliari 36
Orem 36
Boardman 32
Denver 31
Curitiba 30
Chicago 29
Tokyo 28
Buffalo 27
Frankfurt am Main 27
Brooklyn 25
Toronto 25
Warsaw 25
Brno 24
London 24
Amsterdam 23
Chennai 23
Miano 23
San Francisco 23
Campinas 21
Naples 21
Boston 20
Johannesburg 20
The Dalles 20
Fortaleza 19
Palermo 19
Salvador 19
Dhaka 18
Florence 18
Nuremberg 18
Tashkent 18
Turin 18
Guayaquil 17
Haiphong 17
Poplar 17
Seoul 17
Turku 17
Guarulhos 16
Porto Alegre 16
Recife 16
Wilmington 16
Lappeenranta 15
Mexico City 15
Sorocaba 15
Stockholm 15
Ankara 14
Da Nang 14
Falkenstein 14
Houston 14
Baghdad 13
Goiânia 13
Lahore 13
Mumbai 13
Ribeirão Preto 13
Düsseldorf 12
Kingston 12
São José dos Campos 12
Bishkek 11
Brussels 11
Contagem 11
Florianópolis 11
Istanbul 11
Jacksonville 11
Manchester 11
Nairobi 11
New Delhi 11
Santo André 11
Xi'an 11
Alghero 10
Amman 10
Baku 10
Totale 14.354
Salva come PNG Salva come JPEG
Nome #
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 859
Chain of thought reasoning in enhancing infectious disease diagnosis and microbiological analysis 747
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 675
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 674
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 585
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 554
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 543
Diagnostic Performance of ChatGPT-4o in Analyzing Oral Mucosal Lesions: A Comparative Study with Experts 536
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 341
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 298
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 294
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 276
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 276
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 274
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 263
Fluoroquinolones and Biofilm: A Narrative Review 254
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 254
A case of vasculitis-like skin eruption associated with COVID-19 220
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 212
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 197
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 194
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 184
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 178
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 174
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 170
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 165
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 165
Exploring the Impact of Cabotegravir-Rilpivirine Long-Acting on Weight Gain, Body Composition, and Quality of Life in Adults Living with HIV 162
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 159
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 157
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 157
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 156
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 154
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 154
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 149
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 147
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 146
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 143
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 143
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 142
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 142
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 141
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 140
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 139
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 139
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 139
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 138
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 138
Infectious diseases screening approach among refugees: Results from a single-center study 136
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 135
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 132
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 130
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 130
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 128
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 128
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 127
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 127
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 126
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 126
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 123
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 123
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 122
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 122
What do We Know about Cryptic Aspergillosis? 119
Living with HIV and Getting Vaccinated: A Narrative Review 118
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 117
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 116
HBV in Italian Women’s Jail: An Underestimated Problem? 116
The current and future off-label uses of dalbavancin: a narrative review 115
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 114
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 112
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 110
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 110
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges 109
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 109
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 109
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 107
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 106
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 106
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 105
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 104
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 103
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 103
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 103
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 101
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 98
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 97
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 97
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study 95
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 94
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 90
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 89
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 89
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 89
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 89
Enhancing AI Chatbot Responses in Health Care: The SMART Prompt Structure in Head and Neck Surgery 87
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 86
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 86
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 84
Treatment Experienced People Living With HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings From an Italian Multicenter Cohort 80
Totale 18.324
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022164 0 0 0 1 1 4 1 5 8 18 41 85
2022/2023646 44 74 20 96 47 97 25 80 97 15 39 12
2023/2024535 38 28 20 27 194 92 4 7 2 5 34 84
2024/20253.718 50 36 183 136 159 151 387 643 1.139 540 185 109
2025/202612.456 322 1.344 6.909 955 757 331 853 182 276 346 115 66
2026/20272.210 293 476 535 906 0 0 0 0 0 0 0 0
Totale 19.889